/CVS%20Health%20Corp%20corporate%20office-by%20JHVEPhoto%20via%20iStock.jpg)
The stock market kicked off 2025 on a strong note, but the rally quickly lost steam as escalating tariff tensions hammered investor sentiment. The S&P 500 Index ($SPX) slipped into negative territory this year, raising fears of further declines. Even last year’s artificial intelligence (AI)-fueled tech darlings aren’t safe, with broader market headwinds weighing heavily on the sector.
However, interestingly, in the midst of this turmoil, an unexpected healthcare player is defying the odds. CVS Health (CVS) has emerged as the best-performing stock in the S&P 500 this year despite being in the red just a year ago. The company was a market laggard in 2024, plagued by missing earnings expectations and struggling to win over investors. But everything changed in October when David Joyner stepped in as CEO, replacing Karen Lynch.